Daniel Wee doesn’t just translate science; he transforms chemical complexity into compelling narratives that spark action and shape futures. From designing intricate assays and scaling bioreactors to defending critical patents and guiding clinical trials, Daniel has always intertwined science with storytelling—knowing deeply that a well-told story can mobilize teams, attract investors, and profoundly impact lives. At Enveda—a pioneer harnessing AI-powered chemical sequencing to unlock the vast, hidden chemistry of nature for drug discovery—Daniel is the narrative architect who aligns internal teams and external stakeholders around a shared vision. His storytelling helps bridge the intricate world of data-driven discovery and human-centric communication, making groundbreaking innovations accessible and impactful. As Chief eXecution Officer, he formally oversees Chemistry, Manufacturing, and Controls (CMC), Policy, PR & Communications, Legal, and Special Projects. For Daniel, every molecule, every dataset, every discovery holds a story waiting to be told. He passionately believes that the best science not only informs but inspires, connecting deeply with investors, collaborators, and most importantly, the people whose lives will ultimately benefit from these discoveries. Through his unique approach, Daniel ensures Enveda’s story resonates within the biotech industry and beyond, creating a narrative that feels as familiar as it is extraordinary.